Administration of RLYB211 and RLYB212 to expectant at-risk mothers is designed to rapidly eliminate fetal HPA-1a positive platelets from a mother’s circulation and prevent maternal ...

Methods: Prospective investigation of fetal and cerebral neonatal circulation was preformed on 36 neonates: I group - 13 infants with physiologic course maternal pregnancy and 20 ones ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--#Rallybio--Rallybio, a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients ...